copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Home | Global Trial Finder What You Can Expect To Happen In A Clinical Trial Clinical trials are rarely the same They can last from weeks to years, study different doses of a medication, or even compare multiple medications at once While the details change, all trials are structured in a similar way Typically, there are four main parts of a trial, with each part serving a different purpose
A Study of Amivantamab Alone or in Addition to Other . . . - Janssen The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent metastatic head and neck cancer The study will also confirm the recommended Phase 2 combination dose (RP2CD) for
A Phase 1 2 Study of Bleximenib in Participants With Acute Leukemia The purpose of this study is to determine the recommended Phase 2 dose (s) (RP2D [s]) of bleximenib in phase 1 (Part 1 [Dose Escalation] and to determine the safety and tolerability at RP2D in Phase 1 Part 2 (Dose expansion) The purpose of the Phase 2 part of the study is to evaluate the efficacy of bleximenib at the RP2D
Smart Form Report a potential Medical Concern Medical Inquiries Example of potential issues may include (but are not limited to): Signs, such as skin rash, weight loss Symptoms, such as headache, dizziness, nausea Diseases, such as hypertension, diabetes, infection Abnormal Test or Laboratory Findings, such as elevated cholesterol, low potassium Any other untoward condition health consequence that
Nipocalimab in Moderate to Severe Sjogrens Disease (DAFFODIL) This clinical development program for nipocalimab in SjD includes 2 identical double blind, placebo-controlled studies to evaluate the efficacy, safety, and tolerability of nipocalimab in participants greater than or equal to (>=) 18 years of age with moderate to severe SjD
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of . . . The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD)
A Study of JNJ-88549968 for the Treatment of Calreticulin . . . - Janssen The purpose of this study is to characterize safety and to determine the Recommended Phase 2 Dose (RP2D [s]) and optimal dosing schedule (s) of JNJ-88549968, in part 1 (Dose Escalation); to characterize the safety of JNJ- 88549968 at RP2D (s), in part 2 (Cohort Expansion)
Janssen - Discover Johnson Johnson Netherlands At Johnson Johnson, we believe health is everything Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured A world where treatments are smarter, more innovative, less invasive, and solutions are personal Johnson Johnson in the Netherlands houses end-to-end activities, from research to reality This entails Research and